Finance

Lists
8N10:FRA
Biosergen AB
€ 0.040
0.00%
(0.00) 1D
10-р сарын 12, 22:00:00 (GMT+2)  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 8N10...
Open
€ 0.04
High
€ 0.04
Low
€ 0.04
Mkt. cap
39.69 сая
Volume
0.00
52-wk high
€ 4.34
52-wk low
€ 0.04
No. of employees
1
Open
€ 0.04
High
€ 0.04
Low
€ 0.04
Mkt. cap
39.69 сая
Volume
0.00
52-wk high
€ 4.34
52-wk low
€ 0.04
No. of employees
1
News stories
From web sources and news partners
About Biosergen AB
CEOTine Kold Olesen
Employees1
Founded2004
Headquarters-
Sector-
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
131.00 мян
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.73 сая
5.88 сая
5.33 сая
5.33 сая
Operating expense
12.19 сая
9.67 сая
5.24 сая
5.24 сая
Total operating expenses
12.19 сая
9.67 сая
5.24 сая
5.24 сая
Operating income
-12.19 сая
-9.67 сая
-5.24 сая
-5.24 сая
Other non operating income
-
-
-
-
EBT including unusual items
-12.17 сая
-9.66 сая
-5.24 сая
-5.24 сая
EBT excluding unusual items
-12.17 сая
-9.66 сая
-5.24 сая
-5.24 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-537.00 мян
3.79 сая
-95.50 мян
-95.50 мян
Net income
-12.17 сая
-9.66 сая
-5.24 сая
-5.24 сая
Net profit margin
-
-
-
-
Earnings per share
-5.00
-
-
-
Interest and investment income
22.00 мян
18.00 мян
-
-
Interest expense
-
-4.00 мян
-7.50 мян
-7.50 мян
Net interest expenses
22.00 мян
14.00 мян
-7.50 мян
-7.50 мян
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google аппс